Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-22-003152
Filing Date
2022-02-11
Accepted
2022-02-11 17:00:31
Documents
4
Period of Report
2022-04-01

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A arav20220210_def14a.htm DEF 14A 256596
2 arav20220210_def14aimg001.jpg GRAPHIC 3880
3 arav20220210_def14aimg002.jpg GRAPHIC 3880
4 arav20220210_def14aimg003.jpg GRAPHIC 3880
  Complete submission text file 0001437749-22-003152.txt   274192
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36361 | Film No.: 22622370
SIC: 2834 Pharmaceutical Preparations